Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Transpl Int. 2021 Nov;34(11):2031-2045. doi: 10.1111/tri.14128.
Organoid technology is a state-of-the-art cell culture tool that has revolutionized study of development, regeneration, and diseases. Human liver organoids (HLOs) are now derived from either adult stem/progenitors or pluripotent stem cells (PSCs), emulating cellular diversity and structural symphony akin to the human liver. With the rapid rise in decompensated liver disease conditions only treated by liver transplant therapy, HLOs represent an alternate source for transplantation to address the ongoing shortage of grafts. Although ongoing advancements in bioengineering technology have moved the organoid transplant approach to the next level, sustained survival of the transplanted tissue still eludes us toward functional organ replacement. Herein, we review the development of HLOs and discuss promises and challenges on organoid transplant approaches.
类器官技术是一种先进的细胞培养工具,它彻底改变了对发育、再生和疾病的研究。人类肝类器官(HLO)现在可以从成人干细胞/祖细胞或多能干细胞(PSCs)中衍生而来,模拟类似于人类肝脏的细胞多样性和结构交响乐。随着代偿失调性肝病的迅速增加,这些疾病只能通过肝移植治疗,HLO 代表了可供移植的另一种来源,以解决持续存在的供体短缺问题。尽管生物工程技术的不断进步使类器官移植方法更上一层楼,但移植组织的持续存活仍然使我们无法实现功能性器官替代。本文综述了 HLO 的发展,并讨论了类器官移植方法的前景和挑战。